Cincinnati’s newest public company surges on debut

Greater Cincinnati welcomed another public company to its ranks as downtown-headquartered biopharma Blue Water Vaccines began trading on the Nasdaq today — with a huge initial splash.

Blue Water Vaccines, whose lead candidate is a universal flu vaccine, began trading Friday on the Nasdaq capital market under the ticker “BWV.” The company announced the pricing of its $20 million initial public offering Thursday with plans to sell more than 2.2 million shares of its common stock at a public offering price of $9 per share.

Shares opened at $50 — more than 400% above that price. Shares closed at $57.40.

Click here to read the complete story.

Story excerpt provided by Cincy Inno.

Written by Liz Engel.

Originally published February 18, 2022.